Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

888
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
888
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

414
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
414
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

298
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
298

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of <sup>18</sup>F-Choline Positron Emission Tomography - Computed Tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy.

Actas urologicas espanolas·2020
Same author

Usefulness of cardio MRI on thrombosis of coronary aneurysm as an infrequent cause of ST-elevation coronary syndrome.

International journal of cardiology·2009
Same author

[Radiographic staging and bronchoalveolar lavage cell counts in sarcoidosis].

Archivos de bronconeumologia·2005
Same author

[Lymphomatoid papulosis].

Anales de pediatria (Barcelona, Spain : 2003)·2003
Same author

[Evaluation of clinical diagnostic guidelines for idiopathic pulmonary fibrosis].

Archivos de bronconeumologia·2003
Same author

[Aggressive natural killer cell leukemia and presence of Epstein Barr virus].

Revista clinica espanola·2001

Related Experiment Video

Updated: Aug 11, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.1K

Smoking-related interstitial lung disease.

M P Serrano Gotarredona1, S Navarro Herrero1, L Gómez Izquierdo2

  • 1Unidad de Imagen Cardiotorácica, Servicio de Radiodiagnóstico, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

Radiologia
|February 3, 2023
PubMed
Summary

Smoking is linked to interstitial lung diseases like RB-ILD and DIP. A combined diagnostic approach using imaging and histology is recommended for these smoking-related lung conditions.

Keywords:
Diffuse interstitial lung diseaseEnfermedad pulmonar intersticial difusaFibrosisHigh-resolution computed tomography (HRCT)SmokingTabacoTomografía computarizada de alta resolución

More Related Videos

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

851
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

34.2K

Related Experiment Videos

Last Updated: Aug 11, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.1K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

851
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

34.2K

Area of Science:

  • Pulmonology
  • Radiology
  • Pathology

Background:

  • Tobacco smoke exposure is a significant risk factor for airway and lung parenchymal diseases.
  • Smoking is causally linked to interstitial lung diseases including respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) and desquamative interstitial pneumonia (DIP).
  • The precise role of smoking in idiopathic pulmonary fibrosis (IPF) and related entities like combined pulmonary fibrosis and emphysema (CPFE) requires further elucidation.

Purpose of the Study:

  • To describe high-resolution computed tomography (HRCT) findings in smoking-related interstitial lung diseases.
  • To correlate HRCT findings with clinical manifestations and histological changes.
  • To emphasize the importance of a combined diagnostic approach for these complex conditions.

Main Methods:

  • Review of high-resolution computed tomography (HRCT) findings.
  • Correlation of radiological patterns with clinical presentations.
  • Integration of histological data for comprehensive diagnosis.

Main Results:

  • Smoking-related interstitial lung diseases often present with overlapping clinical, radiological, and histological features.
  • A combined diagnostic approach integrating HRCT, clinical context, and histology is crucial for accurate classification.
  • Specific HRCT patterns are associated with distinct smoking-related interstitial lung disease entities.

Conclusions:

  • A multidisciplinary diagnostic strategy is essential for managing patients with suspected smoking-related interstitial lung diseases.
  • Understanding the interplay between smoking, inflammation, and fibrosis is key to diagnosis and treatment.
  • HRCT plays a vital role in characterizing these lung pathologies, aiding in differential diagnosis.